PlainPharmaWatch

CMS Open Payments · Program Year 2024

Shorla Oncology Inc.

Shorla Oncology Inc. reported $797.92 in payments to 31 physicians and teaching hospitals across 31 transactions.

See the rankings → How this is sourced
$797.92
Total payments
31
Transactions
31
Recipients
#1856
of 1,925 companies

Shorla Oncology Inc. reported $797.92 in payments to 31 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1856 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $25.74 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Shorla Oncology Inc. pairs modest payment volume with a broadly spread payment pattern across many recipients.

#1856
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
1
payment categories

How Shorla Oncology Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Shorla Oncology Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$798 4th percentile higher than 4% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). This entry sits in this band. $838–$2,603: 76 reporting companies (4%). Above this entry. $2,603–$8,084: 114 reporting companies (6%). Above this entry. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Shorla Oncology Inc.

$797.92: that is what Shorla Oncology Inc. reported in payments to 31 physicians and teaching hospitals during Program Year 2024, spread across 31 transactions ($25.74 per transaction, $25.74 per recipient). The company sits at rank #1856 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $797.92 across 31 transactions, 100.0% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Shorla Oncology Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $797.92, 100.0% of the company's reported total.

How Shorla Oncology Inc. divides its payments

How the reported total splits across payment categories

1. Food and Beverage$797.92
Payment Type Amount Transactions
Food and Beverage $797.92 31

Recipient Concentration in General Payments

The five largest recipient relationships account for $227.49 (28.5%) of $797.92 in this company's General Payments records across 29 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Shorla Oncology Inc.

The five named recipients with the highest reported General Payments from this company

Neha a Pansuria$64.17Barbara J Phelps$45.43Dedri Markita Ivory$45.43Lisa Kaye Proffitt$38.37Jason Su$34.09
  1. 1

    Neha a Pansuria

    $64.17 across 2 reported transactions

  2. 2

    Barbara J Phelps

    $45.43 across 1 reported transactions

  3. 3

    Dedri Markita Ivory

    $45.43 across 1 reported transactions

  4. 4

    Lisa Kaye Proffitt

    $38.37 across 1 reported transactions

  5. 5

    Jason Su

    $34.09 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $25.74. Average per recipient: $25.74.

Total Amount

$797.92

Avg per Transaction

$25.74

Avg per Recipient

$25.74

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Shorla Oncology Inc. Share

0.0%

#1856 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Shorla Oncology Inc.

SCA Pharmaceuticals, LLC

$806.08 7 recipients

Precision Medical Products Inc.

$832.29 17 recipients

Nuo Therapeutics

$833.09 13 recipients

McKesson Medical-Surgical Minnesota Supply, Inc

$837.57 25 recipients

Omnia S.r.l

$752.44 4 recipients

LockedBrands

$852.39 13 recipients

Frequently Asked Questions

How much did Shorla Oncology Inc. pay to physicians and hospitals in 2024? ▾
Shorla Oncology Inc. made $797.92 in payments to physicians and hospitals in Program Year 2024, across 31 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Shorla Oncology Inc.? ▾
31 physicians and teaching hospitals received payments from Shorla Oncology Inc. in 2024, averaging $25.74 per recipient.
What types of payments did Shorla Oncology Inc. make? ▾
Shorla Oncology Inc. made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $797.92, representing 100.0% of the company's reported total.
How does Shorla Oncology Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Shorla Oncology Inc. ranks #1856 by total payment amount.
What is the average payment size from Shorla Oncology Inc.? ▾
In 2024, Shorla Oncology Inc. averaged $25.74 per transaction across 31 transactions to 31 recipients.
Where does the payment data for Shorla Oncology Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Shorla Oncology Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.